EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSMAMG00000014648
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSMAMG00000016234
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSMAMG00000004035
Gene Symbol: PRKCB
3 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSMAMG00000008935
Gene Symbol: LOC113127803
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSMAMG00000020157
Gene Symbol: LOC113130399
2 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon Type-Like

Ensembl ID : ENSMAMG00000006944
Gene Symbol: LOC113131839
2 Cross references
252 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSMAMG00000023968
Gene Symbol: PRKCDA
2 Cross references
204 Possible Orthologues:

Protein Kinase C, Epsilon A

Ensembl ID : ENSMAMG00000001414
Gene Symbol: PRKCEA
2 Cross references
249 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSMAMG00000001660
Gene Symbol: PRKCHA
3 Cross references
224 Possible Orthologues:

Protein Kinase C, Iota

Ensembl ID : ENSMAMG00000002047
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSMAMG00000017681
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSMAMG00000015153
Gene Symbol: PRKCZ
2 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).